{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:20:01Z","timestamp":1792552801569,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.phymed.2025.156369","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:47:18Z","timestamp":1736182038000},"page":"156369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Celastrol ameliorates fibrosis in Western diet\/tetrachloromethane-induced nonalcoholic steatohepatitis by suppressing Notch\/osteopontin signaling"],"prefix":"10.1016","volume":"137","author":[{"given":"Dingwu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-1291","authenticated-orcid":false,"given":"Xingyong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.156369_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.toxlet.2017.04.012","article-title":"Repression of acetaminophen-induced hepatotoxicity by a combination of Celastrol and brilliant blue G","volume":"275","author":"Abdelaziz","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.phymed.2025.156369_bib0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jhep.2010.03.016","article-title":"Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis","volume":"53","author":"Anstee","year":"2010","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phymed.2025.156369_bib0003","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tem.2015.02.006","article-title":"Notch signaling as a novel regulator of metabolism","volume":"26","author":"Bi","year":"2015","journal-title":"Trends. Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2025.156369_bib0005","article-title":"Molecular and cellular mediators of the gut-liver axis in the progression of liver diseases","volume":"8","author":"Bruneau","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.phymed.2025.156369_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.phymed.2025.156369_bib0007","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2011.05.004","article-title":"NLRP3 inflammasomes link inflammation and metabolic disease","volume":"32","author":"De Nardo","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.phymed.2025.156369_bib0008","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2005.07.021","article-title":"Nicastrin: gatekeeper of the gamma-secretase complex","volume":"122","author":"De Strooper","year":"2005","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0009","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.phymed.2025.156369_bib0010","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.7150\/ijbs.73890","article-title":"Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease","volume":"18","author":"Fan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2025.156369_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41591-019-0358-x","article-title":"IL1R1 is required for Celastrol's leptin-sensitization and antiobesity effects","volume":"25","author":"Feng","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phymed.2025.156369_bib0012","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gde.2009.04.005","article-title":"Endocytic regulation of Notch signaling","volume":"19","author":"Fortini","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.phymed.2025.156369_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114981","article-title":"Celastrol functions as an emerging manager of lipid metabolism: mechanism and therapeutic potential","volume":"164","author":"Gu","year":"2023","journal-title":"Biomed. PharmacOther"},{"issue":"11","key":"10.1016\/j.phymed.2025.156369_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112470","article-title":"Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS\/Akt\/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1\u03b1 protein synthesis","volume":"9","author":"Han","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4093\/dmj.2019.0124","article-title":"Effects of microbiota on the treatment of obesity with the natural product celastrol in rats","volume":"44","author":"Hu","year":"2020","journal-title":"Diabetes. Metab. J."},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0016","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.phymed.2025.156369_bib0017","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2025.156369_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105686","article-title":"Cimigenoside functions as a novel \u03b3-secretase inhibitor and inhibits the proliferation or metastasis of human breast cancer cells by \u03b3-secretase\/Notch axis","volume":"169","author":"Jia","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"25","key":"10.1016\/j.phymed.2025.156369_bib0019","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","article-title":"Apoptosis and non-alcoholic fatty liver diseases","volume":"24","author":"Kanda","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"Suppl: S57\u201363","key":"10.1016\/j.phymed.2025.156369_bib0020","article-title":"Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling","volume":"54","author":"Kim","year":"2012","journal-title":"Prev. Med."},{"key":"10.1016\/j.phymed.2025.156369_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0022","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0023","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jgh.16183","article-title":"Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6\/STAT3-interleukin-17 signaling","volume":"38","author":"Li","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"23","key":"10.1016\/j.phymed.2025.156369_bib0024","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162402","article-title":"Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch\/osteopontin signaling","volume":"7","author":"Li","year":"2022","journal-title":"JCI. Insight."},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with Celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0026","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"Suppl 1","key":"10.1016\/j.phymed.2025.156369_bib0027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver. Int."},{"issue":"8","key":"10.1016\/j.phymed.2025.156369_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081550","article-title":"Mediterranean diet and soy isoflavones for integrated management of the menopausal metabolic syndrome","volume":"14","author":"Marini","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0029","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.phymed.2025.156369_bib0030","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nm.3259","article-title":"Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability","volume":"19","author":"Pajvani","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.phymed.2025.156369_bib0031","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nm.2378","article-title":"Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner","volume":"17","author":"Pajvani","year":"2011","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phymed.2025.156369_bib0032","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-\u03b3","volume":"1","author":"Povero","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156369_bib0033","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.1038\/s41598-023-33924-3","article-title":"Liver-specific overexpression of HKDC1 increases hepatocyte size and proliferative capacity","volume":"13","author":"Pusec","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phymed.2025.156369_bib0034","first-page":"79","article-title":"At the dawn of potent therapeutics for fatty liver disease \u2013 introducing the miniseries on promising pharmacological targets for NASH","author":"Ratziu","year":"2023","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.phymed.2025.156369_bib0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11427-017-9048-8","article-title":"Celastrol specifically inhibits the activation of NLRP3 inflammasome","volume":"61","author":"Sang","year":"2018","journal-title":"Sci. China Life Sci."},{"issue":"17","key":"10.1016\/j.phymed.2025.156369_bib0036","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phymed.2025.156369_bib0037","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phymed.2025.156369_bib0038","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phymed.2025.156369_bib0039","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.phymed.2025.156369_bib0040","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.phymed.2025.156369_bib0041","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phymed.2025.156369_bib0042","first-page":"197","article-title":"NAFLD: a critical role for the NLRP3 inflammasome in NASH","volume":"14","author":"Thomas","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.phymed.2025.156369_bib0043","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.phymed.2025.156369_bib0044","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.phymed.2025.156369_bib0045","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.2337\/db13-0769","article-title":"Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease","volume":"62","author":"Valenti","year":"2013","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.phymed.2025.156369_bib0046","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phymed.2025.156369_bib0047","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.phymed.2025.156369_bib0048","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1002\/ctm2.641","article-title":"Celastrol prevents high-fat diet-induced obesity by promoting white adipose tissue browning","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"8","key":"10.1016\/j.phymed.2025.156369_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166413","article-title":"The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression","volume":"1868","author":"Wang","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2025.156369_bib0050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jcmm.14805","article-title":"Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.phymed.2025.156369_bib0051","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.23167","article-title":"Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis","volume":"50","author":"Witek","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.156369_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105572","article-title":"Celastrol in metabolic diseases: progress and application prospects","volume":"167","author":"Xu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phymed.2025.156369_bib0053","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1021\/acs.analchem.9b05327","article-title":"Molecular imaging and in situ quantitative profiling of fatty acid synthase with a chemical probe","volume":"92","author":"Xu","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phymed.2025.156369_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102134","article-title":"The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox. Biol."},{"issue":"12","key":"10.1016\/j.phymed.2025.156369_bib0055","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1074\/jbc.RA119.011487","article-title":"Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of vitamin D in nonalcoholic fatty liver disease","volume":"295","author":"Zhang","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phymed.2025.156369_bib0056","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcjd.2018.07.002","article-title":"Celastrol reverses palmitic acid-induced insulin resistance in HepG2 cells via restoring the miR-223 and GLUT4 pathway","volume":"43","author":"Zhang","year":"2019","journal-title":"Can. J. Diabetes."},{"issue":"1","key":"10.1016\/j.phymed.2025.156369_bib0057","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2016.11.002","article-title":"Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1","volume":"6","author":"Zhang","year":"2017","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.phymed.2025.156369_bib0058","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1074\/mcp.RA118.000817","article-title":"Celastrol protects from cholestatic liver injury through modulation of SIRT1-FXR signaling","volume":"18","author":"Zhao","year":"2019","journal-title":"Mol. Cell Proteomics."},{"key":"10.1016\/j.phymed.2025.156369_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114058","article-title":"Celastrol ameliorates acute liver injury through modulation of PPAR\u03b1","volume":"178","author":"Zhao","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156369_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114024","article-title":"Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3\/CPT1 pathway","volume":"157","author":"Zheng","year":"2023","journal-title":"Biomed. PharmacOther"},{"issue":"468","key":"10.1016\/j.phymed.2025.156369_bib0061","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci. Transl. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:42:42Z","timestamp":1737603762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":61,"alternative-id":["S0944711325000091"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156369","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol ameliorates fibrosis in Western diet\/tetrachloromethane-induced nonalcoholic steatohepatitis by suppressing Notch\/osteopontin signaling","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156369"}}